Rhabdomyomas and Rhabdomyosarcomas (RMS) David M. Parham, MD Chief of Anatomic Pathology

Similar documents
Aspen conference on pediatric disease. July through August Bone and Soft Tissue Update. David M. Parham, MD. Rhabdomyoma and rhabdomyosarcoma

Diplomate of the American Board of Pathology in Anatomic and Clinical Pathology

5/10. Pathology Soft tissue tumors. Farah Bhani. Mohammed Alorjani

Part 1. Slides 1-38, Rita Alaggio Soft tissue tumors Trondheim 14. mars 2013

Enterprise Interest Nothing to declare

Financial disclosures

Pediatric Soft-Tissue Sarcomas. Beth McCarville, MD St. Jude Children s Research Hospital Memphis, Tn

IN THE NAME OF GOD Dr. Kheirandish Oral and maxillofacial pathology

Newer soft tissue entities

Pathology of Sarcoma ELEANOR CHEN, MD, PHD, ASSISTANT PROFESSOR DEPARTMENT OF PATHOLOGY UNIVERSITY OF WASHINGTON

An Overview of Genital Stromal Tumors

Disclosures. An update on ancillary techniques in the diagnosis of soft tissue tumors. Ancillary techniques. Introduction

ACCME/Disclosures ALK FUSION-POSITIVE MESENCHYMAL TUMORS. Tumor types with ALK rearrangements. Anaplastic Lymphoma Kinase. Jason L.

Classification (1) Classification (3) Classification (2) Spindle cell lesions. Spindle cell lesions of bladder (Mills et al.

57th Annual HSCP Spring Symposium 4/16/2016

Case 1. Disclosure. Imaging. Clinical history 5/10/2016. USCAP 2016 Annual Meeting Evening Specialty Conference Bone and Soft tissue Pathology

Selected Pseudomalignant Soft Tissue Tumors of the Skin and Subcutis

Klinisch belang van chromosomale translocatie detectie in sarcomen

From Morphology to Molecular Pathology: A Practical Approach for Cytopathologists Part 1-Cytomorphology. Songlin Zhang, MD, PhD LSUHSC-Shreveport

3/27/2017. Disclosure of Relevant Financial Relationships

Disclosures. An update on ancillary techniques in the diagnosis of soft tissue tumors. Ancillary techniques. Introduction

Contents Part I Introduction 1 General Description 2 Natural History: Importance of Size, Site, Histopathology

Note: The cause of testicular neoplasms remains unknown

Case Presentation. Maha Akkawi, MD, Fatima Obeidat, MD, Tariq Aladily, MD. Department of Pathology Jordan University Hospital Amman, Jordan

Financial disclosures

Immunohistochemistry in Bone and Soft Tissue Tumors. Sahar Rassi Zankoul, MD

Desmoplastic Melanoma R/O BCC. Clinical Information. 74 y.o. man with lesion on left side of neck r/o BCC

Tumores de células pequeñas, redondas y azules: diagnóstico diferencial cuando el tiempo apremia

Notice of Faculty Disclosure

أملس عضلي غرن = Leiomyosarcoma. Leiomyosarcoma 1 / 5

SOFT TISSUE TUMOR PATHOLOGY: AN UPDATE

Diagnostic Value of Immunohistochemistry in Soft Tissue Tumors

Tumors of Adipose Tissue Tumors Epidemiology Clinical Features. Morphology. Mature Adipocytes Separated by delicate fibrous septa

1/10/2018. Soft Tissue Tumors Showing Melanocytic Differentiation. Overview. Desmoplastic/ Spindle Cell Melanoma

Special slide seminar

Malignant Peripheral Nerve Sheath Tumor

59 yo male with past medical history of prostate carcinoma, presented with upper abdominal pain

Soft Tissue Sarcomas: Questions and Answers

GUT-C 11/30/2017. Debasmita Das, M.D. PGY-1 Danbury Hospital

CASE REPORT Adult onset sinonasal rhabdomyosarcoma - a rare case report with cytohistological features

Mojca Velikonja Jože Pižem

Introduction to Musculoskeletal Tumors. James C. Wittig, MD Orthopedic Oncologist Sarcoma Surgeon

CYSTIC TUMORS OF THE KIDNEY JOHN N. EBLE, M.D. CYSTIC NEPHROMA

Cutaneous Mesenchymal Neoplasms with EWSR1 Rearrangement

A 25 year old female with a palpable mass in the right lower quadrant of her abdomen

Update on Sarcomas of the Head and Neck. Kevin Harrington

3/24/2017 DENDRITIC CELL NEOPLASMS: HISTOLOGY, IMMUNOHISTOCHEMISTRY, AND MOLECULAR GENETICS. Disclosure of Relevant Financial Relationships

Financial disclosures

Musculoskeletal Sarcomas

Spindle Cell Lesions Of The Breast. Emad Rakha Professor of Breast Pathology and Consultant Pathologist

Salivary Glands 3/7/2017

A case of giant cell tumour of soft parts in a horse Francesco Cian 1, Sarah Whiteoak 2, Jennifer Stewart 1

What is New in the 2015 WHO Lung Cancer Classification? Zhaolin Xu, MD, FRCPC, FCAP

Mayo Medical Laboratories

Pathology Mystery and Surprise

Update On Lipomatous Tumors: Old Standbys and New Concepts

Grading of Bone Tumors

The Relevance of Cytologic Atypia in Cutaneous Neural Tumors

A 42-year-old woman with a liver mass

Diagnostically Challenging Cases in Gynecologic Pathology

Case 2. Dr. Sathima Natarajan M.D. Kaiser Permanente Medical Center Sunset

Cellular Neurothekeoma

Update on Cutaneous Mesenchymal Tumors. Thomas Brenn

Surgical Pathology Evening Specialty Conference USCAP 2015

Lung Tumor Cases: Common Problems and Helpful Hints

2 to 3% of All New Visceral Cancers Peak Incidence is 6th Decade M:F = 2:1 Grossly is a Bright Yellow, Necrotic Mass with a Pseudocapsule

Disclosure. Relevant Financial Relationship(s) None. Off Label Usage None MFMER slide-1

Case Presentations 17-20

Fun with Fat. General Rules. Case

Molecular Diagnosis of Soft Tissue Tumors: Avoid Pitfalls

A Clinicopathologic and Immunohistochemical Study of Five Cases

Evening Specialty Conference Bone and Soft Tissue Pathology. Diagnostic pitfalls in bone and soft tissue pathology

Atypical Palisaded Myofibroblastoma of Lymph Node: Report of a rare case.

Case Presentation. Gordon Callender M.D. Surgical Resident

Differential diagnosis of hematolymphoid tumors composed of medium-sized cells. Brian Skinnider B.C. Cancer Agency, Vancouver General Hospital

IMMUNOHISTOCHEMISTRY IN THE DIAGNOSIS OF SOFT TISSUE TUMORS

Procedures Cytology (No Accompanying Checklist) Incisional Biopsy (Needle or Wedge) (No Accompanying Checklist) Resection

RENAL CELL CARCINOMA 2 to 3% of All New Visceral Cancers Peak Incidence is 6th Decade M:F = 2:1 Grossly is a Bright Yellow, Necrotic Mass with a Pseud

Pathological Classification of Hepatocellular Carcinoma

INDEX. in this web service Cambridge University Press

SMOOTH MUSCLE TUMOURS

Pelvic tumor in childhood Classification, imaging approach and radiological findings

Molecular Genetics of Paediatric Tumours. Gino Somers MBBS, BMedSci, PhD, FRCPA Pathologist-in-Chief Hospital for Sick Children, Toronto, ON, CANADA

ESS: Pathologic Insights

Gross appearance of peritoneal cysts. They have a thin, translucent wall and contain a clear fluid.

Neoplasia part I. Dr. Mohsen Dashti. Clinical Medicine & Pathology nd Lecture

Difficult Diagnoses and Controversial Entities in Neoplastic Lung

05/07/2018. Types of challenges. Challenging cases in uterine pathology. Case 1 ` 65 year old female Post menopausal bleeding Uterine Polyp

Ocular Neoplasia What s Common? What s New? Richard R Dubielzig

Affiliazione autori0. Riccardo Ricci Journal Club GIPAD, settore GIST Anatomia Patologica, Università Cattolica, Roma

Prognostic Significance of Grading and Staging Systems using MIB-1 Score in Adult Patients with Soft Tissue Sarcoma of the Extremities and Trunk

Normal endometrium: A, proliferative. B, secretory.

No financial or other disclosures

Sarcomatoid (spindle cell) carcinoma of the cricopharynx presenting as dysphagia

Dystrophin Is a Tumor Suppressor in Human Cancers with Myogenic Programs

number Done by Corrected by Doctor Maha Shomaf

Cerebral Parenchymal Lesions: I. Metastatic Neoplasms

Disclosure of Relevant Financial Relationships

LAC + USC.

Keywords solitary fibrous tumor, dedifferentiation, dedifferentiated solitary fibrous tumor, STAT6, GRIA2, cytokeratin, rhabdomyosarcomatous

Transcription:

Rhabdomyomas and Rhabdomyosarcomas (RMS) David M. Parham, MD Chief of Anatomic Pathology

Tumors of skeletal muscle: Rhabdomyomas and rhabdomyosarcomas Embryonal muscle 2

3

4

5

6

7

8

Rhabdomyoma Benign soft tissue counterpart of RMS Rare (<2% of soft tissue neoplasms) Cardiac and non-cardiac types Cardiac more common, associated with tuberous sclerosis Non-cardiac types Fetal Adult Genital

Fetal Rhabdomyoma Clinical Features Most patients <3 years of age More common in boys Sporadic or associated with Gorlin syndrome Most common in head and neck Post-auricular region is favored site Much less common than rhabdomyosarcoma (1:50)

Fetal Rhabdomyoma Histologic Features Parallel bundles of spindle cells and myoid tubules Separated by less differentiated cells Biphasic pattern No significant nuclear pleomorphism Low mitotic activity (<1/10 HPFs) Intermediate forms may resemble adult rhabdomyosarcomas and contain smooth and skeletal muscle

12

Spindle cell rhabdomyosarcoma Embryonal rhabdomyosarcoma Differential points No cambium layer Fetal Rhabdomyoma Differential Diagnosis RMS has higher mitotic rate (>5/10 HPFs) Circumscription: RMS not well circumscribed Should be PRE-treatment material for differential dx 13

Fetal Rhabdomyoma Immunohistochemistry Markers of differentiated muscle Myoglobin Desmin Actin (smooth and skeletal muscle Not useful in distinction from RMS Negative: Keratin CD68 (useful for rhabdomyoma-like histiocytic tumors, sometimes desmin-positive) 14

Fetal Rhabdomyoma Genetics Gorlin syndrome mutation: PTCH1 Negative regulator of hedgehog signaling pathway Pathway may also be activated in sporadic, non-syndromic tumors 15

Adult Rhabdomyoma Rare benign neoplasm Composed of mature, differentiated muscle Typically occurs after adolescence

Usually in Oral cavity Adult Rhabdomyoma Clinical Features Superficial soft tissue of head and neck Origin from bronchial musculature? Mean age: 50 years Rare pediatric cases Up to 20% are multifocal Local recurrences possible, even years after operation 17

Gross: Brown lobulated mass Micro: Large round and polygonal cells Uniform cytology PAS positive due to glycogen Cross-striations may be seen. Adult Rhabdomyoma Pathologic Features 18

19

Adult Rhabodyoma Differential Diagnosis Granular cell tumor (S100 positive, desmin negative) Hibernomas (S100 positive, desmin negative) Crystal storing histiocytosis (CD68 positive, desmin negative, crystals on EM) 20

Genital Rhabdomyoma Benign myogenic tumor of female genital tract Possible origin from myogenic stem cells in subepithelial stroma Usually in vagina or cervix of reproductive age women May be pregnancy-associated Male genital lesions occur, but more like fetal rhabdomyoma Female lesions resemble adult rhabdomyoma No significant pleomorphism Focal cross striations

Miscellaneous Benign Myogenous Tumors Neuromuscular choristoma ( benign Triton tumor ) A hamartomatous lesion of peripheral nerve Muscle within perineurial sheath Most in head and neck May have associated rhabdomyoma

Benign Triton Tumor Desmin and EMA 23

Miscellaneous Benign Myogenous Tumors Rhabdomyomatous mesenchymal hamartoma Head and neck lesions Affects skin of newborn and infant ages Polypoid skin tags or mouth lesions containing benign skeletal muscle Myotubes, cross-striations 24

Benign rhabdomyomatous hamartoma 25

Focal Myositis Solitary mass Degenerating and regenerating skeletal muscle Infiltrates of macrophages and lymphocytes Secondary to focal denervation? Relationship to polymyositis? Only occasional association

Rhabdomyosarcoma Soft tissue tumor with features of embryonic or fetal myogenesis Most common soft tissue sarcoma in children Can be subclassified into multiple, distinct clinical and genetic entities Embryonal Alveolar Spindle cell Pleomorphic (adult)

Rhabdomyosarcoma Introduction and Clinical Features: General Most present as painless mass Rarely have systemic problems, e.g. hypercalcemia Symptoms may relate to affected organ Proptosis Urinary retention Bile retention 28

29

May be affected by genetic syndrome P53 Beckwith-Wiedemann Neurofibromatosis 1 Gorlin DICER mutation-associated (pleuropulmonary blastoma) 30

Rhabdomyosarcoma Pathologic Features: General Only some arise in extremity skeletal muscle; most do not Histology resembles developing or disordered muscle Rhabdomyoblast is key cell Undifferentiated blastoma cells Occasional multinucleated cells Differentiated myoblasts (more common after therapy) 31

Primitive Differentiated 32

Embryonal Rhabdomyosarcoma A primitive soft tissue tumor with features of embryonic skeletal muscle

Embryonal Rhabdomyosarcoma Clinical Features Over one half of rhabdomyosarcoma Most occur in children <10 years of age Rare in adults Botryoid type forms polypoid masses in vagina, bladder, mouth, or bile ducts 34

35

Embryonal Rhabdomyosarcoma Histologic Features Haphazard arrangement with areas of myxoid stroma Compact areas Loose and dense pattern resembling nascent muscle Some predominantly loose, others predominantly dense Much variation in cytology Strap cells, spider cells, racket cells, etc., with bright eosinophilic cytoplasm Undifferentiated, slightly spindled cells with oblong nuclei Cambium layer in botryoid variant 36

ERMS 37

ERMS 38

Embryonal Rhabdomyosarcoma Genetics No single specific mutation Recurring pattern of chromosome gains and losses Profound loss of heterozygosity on chromosome 11p Affects Beckwith-Wiedemann locus (11p15.5) Associated with imprinting abnormalities Loss of maternal allele in syndromic cases

ERMS 40

Embryonal Rhabdomyosarcoma (ERMS) Differential Diagnosis Malignant peripheral nerve sheath tumor (MPNST) Triton tumor contains ERMS-like foci MPNST may be positive with some muscle markers Myofibroblastic tumors Inflammatory myofibroblastic tumors (often ALK1 positive, but so is ERMS) Inflammatory or reactive processes Eosinophilic cystitis, beware on frozen section

Spindle Cell/Sclerosing Rhabdomyosarcoma Spindle cell lesion resembling fibrosarcoma or smooth muscle neoplasm May be hyalinized with abundant collagen (sclerosing RMS)

Spindle Cell/Sclerosing Rhabdomyosarcoma Clinical Features Predilection for paratesticular region in boys Head and neck Extremities Good prognosis in children (different tumor?) Bad prognosis in adults 43

Spindle Cell/Sclerosing Rhabdomyosarcoma Histologic Features Spindle cells with elongate borders Must comprise >80% of tumor (overlap with ERMS) Should have definitive skeletal muscle phenotype Some smooth muscle features Some areas may be positive for smooth muscle actin Isolated, well-differentiated cells with cross striations may be found Variable collagen 44

Spindle cell ERMS 45

Sclerosing rhabdomyosarcoma Hyalinizing collagen with entrapment of tumor cells defines sclerosing variant Osteoid-like Can have a small cell component that resembles an alveolar pattern 46

Sclerosing RMSA 47

Spindle Cell/Sclerosing Rhabdomyosarcoma Genetics Adult spindle cell RMS: 40% have activating mutations in MyoD1 gene (located in chromosome 11p) Infantile spindle cell RMS May have NCOA2 rearrangements Should be negative for PAX gene and FOXO1 rearrangement

Spindle Cell/Sclerosing Rhabdomyosarcoma Differential Diagnosis Leiomyosarcoma (myogenin negative) Fibrosarcoma (desmin negative) Synovial sarcoma (positive for SS18 rearrangement, negative for myogenin, typically negative for desmin) Spindle cell carcinoma (usually adults) Osteosarcoma (vs sclerosing RMS, myogenin-negative) Angiosarcoma (CD31-positive)

Alveolar Rhabdomyosarcoma A small cell neoplasm Patternless sheets of cells or alveolar pattern Often (always?) positive for FOXO1 fusion

Usually extremity Alveolar Rhabdomyosarcoma Clinical Features Head and neck (sinonasal tumors in particular) Parameningeal Metastasize to regional lymph nodes Predominate in older children, adolescents Also occur in younger children, adults Incompletely excised lesions recur with drug resistance Rare lesions present as leukemia 51

ARMS 52

Alveolar pattern Alveolar Rhabdomyosarcoma Pathologic Features Cells lining a hollow space (L. alveolus, cavity) Central floating clusters Peripheral discohesion or cracking Fibrous septa Solid pattern Patternless sheets No apparent alveolar spaces or septa 53

ARMS 54

ARMS, solid variant 55

t(2;13) Alveolar Rhabdomyosarcoma (ARMS) Genetics PAX3-FOXO1 fusion About 60% of cases Overexpressed t(1;13) PAX7-FOXO1 fusion About 20% of cases Amplified PAX fusion negative Are these truly ARMS?

t(2;13) 57

ARMS FISH 58

Fusion vs. histology (Davicioni et al). 59

Alveolar Rhabdomyosarcoma Differential Diagnosis ERMS (fusion negative, with rare exceptions) Ewing sarcoma Lymphoma Neuroblastoma Synovial sarcoma Other round cell neoplasms

Pleomorphic Rhabdomyosarcoma A high grade sarcoma that usually arises in the extremities Features similar to other high grade adult sarcomas Should have definitive skeletal myogenesis, by definition May require immunohistochemistry, i.e. myogenin stain

Pleomorphic Rhabdomyosarcoma Clinical Features Lower extremity lesion most common Other sites, abdomen, chest wall, spermatic cord, arm, mouth, orbit Ages: 21-81 years (median 54 years) Clinical outcome: 70% die, mean survival 20 months 62

Pleomorphic Rhabdomyosarcoma Pathologic Features Pleomorphic spindle cells and giant cells May have malignant fibrous histiocytoma -like (storiform) pattern Cells with eosinophilic cytoplasm Woven, streaming, or indistinct pattern Must demonstrate features of skeletal muscle Myogenin and MyoD may be negative or focal in some cases Desmin should be positive, but is non-specific Cytological features should be present 63

Pleomorphic RMS 64

Few good studies Pleomorphic Rhabdomyosarcoma Genetics Regions of chromosomal gain and loss Regions of gene amplification Genetic features of osteosarcoma

Pleomorphic Rhabdomyosarcoma Differential Diagnosis Undifferentiated pleomorphic sarcoma (MFH) Dedifferentiated liposarcoma (MDM2 expression, 12p12-15 region amplification Dedifferentiated chondrosarcoma (bone tumor) Melanoma (HMB45, other melanocytic markers) Spindle cell carcinoma Carcinosarcoma

Epithelioid/Rhabdoid Rhabdomyosarcoma A newly-described RMS variant with features of carcinoma or rhabdoid tumor Rhabdoid tumor features more typical with children Probable variant of ERMS Fusion-negative Weak or focal myogenin Other differential diagnosis features INI1 retained Melanocyte markers negative (beware of desmin-positive melanoma)

Immunohistochemistry of Rhabdomyosarcoma General markers of muscle differentiation Muscle actin Desmin Specific markers of skeletal muscle differentiation MyoD (myf3) Must be nuclear stain to be positive Myogenin (myf4) Myoglobin (terminal differentiation) 68

Myogenin ARMS ERMS 69

Surrogate Markers of Fusion Status in Rhabdomyosarcoma Strong expression Myogenin NOS-1 AP2β P-cadherin Weak expression HMGA2 EGFR Fibrillin-2

Prognosis and Clinical Course of Rhabdomyosarcoma Stage Stage Sites T T Size Node Status Metastases 1 Favorable site (orbit; head and neck, excluding parameningeal; and genitourinary, nonbladder/prostate) T1 or T2 Any N0, N1 or NX M0 2 Unfavorable site (any site not listed above) T1 or T2 <5 cm N0 or NX M0 3 Unfavorable site T1 or T2 <5 cm N1 M0 >5 cm N0, N1 or NX 4 Any T1 or T2 Any N0, N1 or NX M1

Prognosis and Clinical Course of Rhabdomyosarcoma Group Group I: Completely resected, non-metastatic Group 2: Microscopic residual disease non-metastatic resected nodal metastatic Group 3: Gross residual disease Group 4: Distant metastasis 72

Prognosis and Clinical Course of Rhabdomyosarcoma Prognostic groups Risk Group Stage/Group Fusion Status Low Stage 1, Group III (orbit) Negative Stage 1, Group I-II Stage 2, Group I-II Intermediate, subset 1 Stage 1, Group III (non-orbit) Negative Stage 3, Group I-II Intermediate, subset 2 Stage 2-3, Group III Negative Stage 1-3, Group I-III Positive Intermediate, subset 3 Stage 4, Group IV Negative High Stage 4, Group IV Positive

Failure free survival 74

Summary Rhabdomyoma is a rare benign tumor of adults and children Rhabdomyosarcoma is more common, malignant, and usually affects children Diagnosis is improved with immunohistochemistry Prognosis depends on stage, group, and PAX fusion status 75